Did SOX influence the association between fee dependence and auditors' propensity to issue going-concern opinions?

by Kao, J.L., Li, Y., Zhang, W.
Published 2016

Has SOX enhanced non-big 4 auditors' ability to deal with client pressure?

by Kao, J.L., Li, Y., Zhang, W.
Published 2016

Prevention of hepatocellular carcinoma in hepatitis B virus infection

by Lim, S.G., Mohammed, R., Yuen, M.-F., Kao, J.-H.
Published 2011

Magnetic nanoparticle-driven pumping in microchannels

by Tsai, K.L., Pickard, D., Kao, J., Yin, X., Leen, B., Knutson, K., Kant, R., Howe, R.T.
Published 2014

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis

by Kao J., Tung S., Lee Y., Thongsawat S., Tanwandee T., Sheen I., Wu J., Li H., Brennan B., Zhou J., Le Pogam S., Najera I., Thommes J., Hill G.
Published 2017

Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy

by Lui, Y.Y.N., Tsoi, K.K.F., Wong, V.W.S., Kao, J.H., Hou, J.L., Teo, E.K., Mohamed, R., Piratvisuth, T., Han, K.H., Mihm, U., Wong, G.L.H., Chan, H.L.Y.
Published 2010

Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

by Farrell, G.C., Chan, H.L.Y., Yuen, M.F., Amarapurkar, D.N., Chutaputti, A., Fan, J.G., Hou, J.L., Han, K.H., Kao, J.H., Lim, S.G., Mohamed, R., Sollano, J., Ueno, Y., Prevent, Asai-Pacific Working Party
Published 2010

APASL consensus statements and management algorithms for hepatitis C virus infection

by Omata, M., Kanda, T., Yu, M.-L., Yokosuka, O., Lim, S.-G., Jafri, W., Tateishi, R., Hamid, S.S., Chuang, W.-L., Chutaputti, A., Wei, L., Sollano, J., Sarin, S.K., Kao, J.-H., McCaughan, G.W.
Published 2016